Compare DELL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DELL | TNDM |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.6B | 1.5B |
| IPO Year | 1988 | 2013 |
| Metric | DELL | TNDM |
|---|---|---|
| Price | $129.66 | $21.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 16 |
| Target Price | ★ $164.60 | $22.44 |
| AVG Volume (30 Days) | ★ 7.7M | 2.1M |
| Earning Date | 11-25-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | ★ 24.77 | N/A |
| EPS | ★ 7.50 | N/A |
| Revenue | ★ $104,090,000,000.00 | $1,007,001,000.00 |
| Revenue This Year | $18.16 | $8.59 |
| Revenue Next Year | $10.93 | $10.19 |
| P/E Ratio | $17.34 | ★ N/A |
| Revenue Growth | 10.79 | ★ 17.87 |
| 52 Week Low | $66.25 | $9.98 |
| 52 Week High | $168.08 | $38.28 |
| Indicator | DELL | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 64.60 |
| Support Level | $132.61 | $20.27 |
| Resistance Level | $141.13 | $22.10 |
| Average True Range (ATR) | 4.79 | 1.13 |
| MACD | 0.98 | -0.10 |
| Stochastic Oscillator | 34.06 | 80.51 |
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.